Moreover, clinical NSCLC patients with low-level of inactive GSK3β and high-level LCRMP-1 protein expression is associated with poor overall survival than those with high-level inactive form GSK3β expression and low-level LCRMP-1 expression (Fig. 5B). Here, GSK3B is linked to non-small cell lung carcinoma.